Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Completed Phase 3 Interventional

MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder

ClinicalTrials.gov ID: NCT01161615

Public ClinicalTrials.gov record NCT01161615. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Sep 5, 2026, 3:04 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

A Randomized, Multi-Center, Double-Blind, Placebo-Controlled Phase III Trial to Evaluate the Efficacy, Tolerability and Safety of MRX-7EAT Etodolac-Lidocaine Topical Patch in the Treatment of Tendonitis and Bursitis of the Shoulder.

Study identification

NCT ID
NCT01161615
Recruitment status
Completed
Study type
Interventional
Phase
Phase 3
Lead sponsor
MEDRx USA, Inc.
Industry
Enrollment
350 participants

Conditions and interventions

Interventions

Drug

Eligibility (public fields only)

Age range
14 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Jun 30, 2010
Primary completion
May 31, 2011
Completion
May 31, 2011
Last update posted
Jan 16, 2018

2010 – 2011

United States locations

U.S. sites
35
U.S. states
17
U.S. cities
34
Facility City State ZIP Site status
Not listed Chandler Arizona 85224
Not listed Phoenix Arizona 85050
Not listed North Little Rock Arkansas 72114
Not listed Chico California 95929
Not listed Mission Hills California 91345
Not listed Palm Springs California 92262
Not listed San Diego California 92120
Not listed Aurora Colorado 80014
Not listed Colorado Springs Colorado 80907
Not listed Denver Colorado 80239
Not listed Daytona Beach Florida 32114
Not listed Fort Lauderdale Florida 33334
Not listed Gulf Breeze Florida 32561
Not listed Orlando Florida 32804
Not listed West Palm Beach Florida 33409
Not listed Avon Indiana 46123
Not listed Fishers Indiana 46038
Not listed Franklin Indiana 46131
Not listed Greenfield Indiana 46140
Not listed Muncie Indiana 47304
Not listed Dubuque Iowa 52001
Not listed Dubuque Iowa 52002
Not listed Wichita Kansas 67206
Not listed Erlanger Kentucky 41018
Not listed Henderson Nevada 89052
Not listed Charlotte North Carolina 28207
Not listed Fargo North Dakota 58103
Not listed Cincinnati Ohio 45246
Not listed Oklahoma City Oklahoma 73112
Not listed Georgetown Texas 78626
Not listed Lubbock Texas 79410
Not listed San Antonio Texas 78229
Not listed Temple Texas 76502
Not listed Riverton Utah 84065
Not listed Danville Virginia 24541

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT01161615, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jan 16, 2018 · Synced Sep 5, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT01161615 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →